Centre for Digestive Diseases
The Centre for Digestive Diseases (CDD) in Sydney, Australia, is a globally recognized center of excellence specializing in advanced treatments and research in digestive diseases. Led by Dr. Thomas Borody, the center is known for pioneering fecal microbiota transplantation (FMT) and other innovative therapies, with a focus on improving patient outcomes through cutting-edge technology, clinical trials, and knowledge sharing.
Industries
Nr. of Employees
medium (51-250)
Centre for Digestive Diseases
Rodd Point, New South Wales, Australia
Patents
Compositions and methods for treating Crohn's Disease and related conditions and infections
US-11938184-B2
View DetailsMethods for treating, ameliorating or preventing infections using drug and vaccination combination treatment
US-11857617-B2
View DetailsCompositions and methods for treating, ameliorating and preventing H. pylori infections
US-11833140-B2
View DetailsCompositions and methods for treating, ameliorating and preventing H. pylori infections
US-11033536-B2
View DetailsCompositions and methods for treating Crohn's disease and related conditions and infections
US-10946091-B2
View DetailsCompositions and methods for treating Crohn's disease and related conditions and infections
US-10376578-B2
View Details
Compositions and methods for treating Crohn's Disease and related conditions and infections
US-11938184-B2
View DetailsMethods for treating, ameliorating or preventing infections using drug and vaccination combination treatment
US-11857617-B2
View DetailsCompositions and methods for treating, ameliorating and preventing H. pylori infections
US-11833140-B2
View DetailsCompositions and methods for treating, ameliorating and preventing H. pylori infections
US-11033536-B2
View DetailsCompositions and methods for treating Crohn's disease and related conditions and infections
US-10946091-B2
View DetailsCompositions and methods for treating Crohn's disease and related conditions and infections
US-10376578-B2
View DetailsProducts
RESTOBA
FMT product provided via prescription to gastroenterologists for microbiome restoration in conditions ranging from resistant Clostridium difficile infection to Inflammatory Bowel Disease and Irritable Bowel Syndrome.
Donor Bank FMT Product
Screened human donor microbiota product utilized for fecal microbiota transplantation procedures to restore healthy gut bacteria.
Product With Accordion Contents
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla at erat interdum velit eleifend ornare nec ut erat.
Product With Accordion Contents 2
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla at erat interdum velit eleifend ornare nec ut erat.
Product With Horizontal Tabs
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla at erat interdum velit eleifend ornare nec ut erat.
Product With Vertical Tabs 2
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla at erat interdum velit eleifend ornare nec ut erat.
RESTOBA
FMT product provided via prescription to gastroenterologists for microbiome restoration in conditions ranging from resistant Clostridium difficile infection to Inflammatory Bowel Disease and Irritable Bowel Syndrome.
Donor Bank FMT Product
Screened human donor microbiota product utilized for fecal microbiota transplantation procedures to restore healthy gut bacteria.
Product With Accordion Contents
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla at erat interdum velit eleifend ornare nec ut erat.
Product With Accordion Contents 2
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla at erat interdum velit eleifend ornare nec ut erat.
Product With Horizontal Tabs
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla at erat interdum velit eleifend ornare nec ut erat.
Product With Vertical Tabs 2
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla at erat interdum velit eleifend ornare nec ut erat.
Services
Provision of fecal microbiota transplantation for specified indications (e.g., recurrent C. difficile, IBS, constipation, ulcerative colitis) including donor selection, preparation and administration.
Remote clinical consultations delivered via video conferencing for assessment, follow-up and pre-procedure planning.
Face-to-face specialist consultations and outpatient procedures with sedation, scheduling, and post-procedure monitoring.
Recruitment, screening and management of stool donors and maintenance of donor material for clinical use.
Support for and participation in investigator-initiated and industry-sponsored clinical trials, including patient recruitment and trial-related clinical activities.
Provision of individualized therapeutic preparations manufactured through a compounding chemist partner to meet clinical requirements.
Provision of fecal microbiota transplantation for specified indications (e.g., recurrent C. difficile, IBS, constipation, ulcerative colitis) including donor selection, preparation and administration.
Remote clinical consultations delivered via video conferencing for assessment, follow-up and pre-procedure planning.
Face-to-face specialist consultations and outpatient procedures with sedation, scheduling, and post-procedure monitoring.
Recruitment, screening and management of stool donors and maintenance of donor material for clinical use.
Support for and participation in investigator-initiated and industry-sponsored clinical trials, including patient recruitment and trial-related clinical activities.
Provision of individualized therapeutic preparations manufactured through a compounding chemist partner to meet clinical requirements.
Expertise Areas
- Fecal microbiota transplantation therapy
- Clinical trial management and participation
- Gastroenterology clinical care (IBD, IBS, C. difficile, H. pylori, parasites)
- Microbiome therapeutics development
Key Technologies
- Fecal microbiota transplantation
- Stool banking and donor screening
- Microbiota processing and preservation (frozen/encapsulated)
- Infrared coagulation for haemorrhoids
News & Updates
A notable research project and publication on fecal microbiota transplantation.
News about Westmead Hospital's new treatment options involving fecal transplants.
Latest research developments led by Dr. Borody and team.
Research articles and breakthroughs by Dr. Borody in microbiota and GI diseases.
Discussion on Crohn's disease and innovative treatments by Prof. Thomas Borody.
Studies on microbiota transfer therapy and its effects on gastrointestinal and autism symptoms.
A notable research project and publication on fecal microbiota transplantation.
News about Westmead Hospital's new treatment options involving fecal transplants.
Latest research developments led by Dr. Borody and team.
Research articles and breakthroughs by Dr. Borody in microbiota and GI diseases.
Discussion on Crohn's disease and innovative treatments by Prof. Thomas Borody.
Studies on microbiota transfer therapy and its effects on gastrointestinal and autism symptoms.